Previous studies have also shown that ATF3 plays a crucial role in regulating lipid metabolism and hepatic steatosis, consistent with our findings.[36, 37, 48] These findings provide valuable insight into the source of GSN induction in hepatocytes during MASH and hold significant implications. The gene discussed is ATF3; the disease is fatty liver disease.